Tag

Cvs Caremark

All articles tagged with #cvs caremark

CVS Caremark Reverses, Restores Zepbound Coverage Amid Patient Backlash
healthcare4 days ago

CVS Caremark Reverses, Restores Zepbound Coverage Amid Patient Backlash

CVS Caremark will reinstate Lilly’s weight‑loss drug Zepbound on its standard formulary by Oct. 1 after patient backlash over its prior removal, which had pressured some users to switch to Wegovy. The change, affecting about 25–30 million people, does not guarantee coverage for all employer plans but may widen access; Lilly says some private plans could offer as little as a $25 copay. Lilly’s Foundayo will also be added to the formulary starting Monday. Zepbound’s list price is around $1,086 per month before discounts, and a related class‑action lawsuit over the initial formulary decision remains active. Express Scripts and Optum Rx already cover Zepbound.

CVS Restores Zepbound Coverage, Adds Lilly’s Foundayo to Standard Plans
business4 days ago

CVS Restores Zepbound Coverage, Adds Lilly’s Foundayo to Standard Plans

CVS Caremark will restore coverage for Eli Lilly’s Zepbound on Oct. 1 and start covering Lilly’s obesity pill Foundayo on June 1 on its standard drug plans, putting Lilly and Novo Nordisk on equal footing in major plans and expanding access for patients. The change follows CVS’s previous deal that favored Novo Nordisk’s Wegovy, and Caremark’s formulary will offer co‑preferred GLP-1 options for weight loss, though sponsors can opt out, meaning coverage isn’t guaranteed for all. CVS expects the shifts to drive 10%–15% savings in the weight‑management category as Lilly and Novo Nordisk negotiate pricing.”,

"Arizona Resident's Concerns Grow as Access to Medications is Threatened by Pharmacy Letter"
healthcare2 years ago

"Arizona Resident's Concerns Grow as Access to Medications is Threatened by Pharmacy Letter"

An Arizona resident received a letter from CVS Caremark stating that their medications will only be covered through a 90-day prescription supply program offered exclusively by CVS. If the consumer wants to use a different pharmacy, they must actively opt out. The letter caused concern for the resident, who feared losing access to their medications or having to pay a significant amount out of pocket. After reaching out for clarification, the resident learned that the letter was meant to explain a cost-saving program for CVS users, not a mandated change. However, the resident still expressed stress and requested a change in the wording of the letter.